Loopbaan van Harish Shantharam
Eerdere bekende functies van Harish Shantharam
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 24-01-2024 | 22-03-2024 |
| Financieel Directeur/CFO | 22-05-2023 | 22-03-2024 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01-10-2011 | 01-05-2022 |
| AMGEN INC. | Corporate Officer/Principal | 01-01-2004 | 01-11-2011 |
Opleiding van Harish Shantharam
| UCLA Anderson School of Management | Masters Business Admin |
| The University of Texas at Arlington | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
- Beurs
- Insiders
- Harish Shantharam
- Ervaring